Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01894 |
| Species: | Homo sapiens |
| Position : | chr14:56793806-56795906 |
| Year: | 2025 |
| Title: | Targeting TET3 suppresses group 3 medulloblastoma stemness and progression via impairing hypomethylation of Otx2 super-enhancer |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 41338221 |
| MONDO: | |
| Tissue: | Blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | Lymphoblastoid |
| CVCL ID: | |
| Cell Type: | lymphoblastoid cell |
| Cell Ontology ID: | CL:0000945 |
| Experiment Type: | Super-enhancer activity assay, Functional perturbation assay |
| High Throughput Method: | WGBS, CUT&Tag |
| Low Throughput Method: | Luciferase reporter assay, ChIP-RT-qPCR, RT-RT-qPCR |
| Target gene : | OTX2 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|